상세 보기
초록
A mixture of tegafur and uracil (TEGASIL) is a common antineoplastic agent. Tegafur is a fluoropyrimidine structurally similar to 5-fluorouracil (5-FU); uracil slows the degradation of 5-FU by dihydropyrimidine dehydrogenase, which results in higher 5-FU concentrations in tumors. Mucocutaneous side effects induced by this agent are rare and include photosensitivity of lichenoid and eczematous types, acral erythema, hyperpigmentation and palmoplantar keratoderma. However, there have been no reports of fixed drug eruption associated with TEGASIL. We report here on a case of fixed drug eruption due to oral TEGASIL. (Korean J Dermatol 2010;48(2):155-157).
키워드
Fixed drug eruption; Tegafur; Tegasil
- 제목
- Tegafur-Uracil(TEGASIL) 경구 투여 후 발생한 고정 약진 1예
- 제목 (타언어)
- A case of fixed drug eruption induced by tegafur-uracil(tegasil)
- 저자
- 허영수; 송해준; 오칠환
- 발행일
- 2010-02
- 유형
- Article
- 저널명
- 대한피부과학회지
- 권
- 48
- 호
- 2
- 페이지
- 155 ~ 157
- 언어
- KOR
- 출판사
- 대한피부과학회
- 발행국가
- 대한민국
- 분량
- 3 페이지
- ISSN
- P 0494-4739